Physical status and expression of HPV genes in cervical cancers

Gynecologic Oncology

Volumn 65, Issue 1, 1997, Pages 121-129

  Park, Jong Sup ^a,b   Hwang, Eun Seong ^c   Park, Sue Nie ^d   Ahn, Hee Kyung ^a   Um, Soo Jong ^a   Kim, Chan Joo ^a   Kim, Seung Jo ^a   Namkoong, Sung Eun ^b  

^a The Catholic University of Korea   (South Korea)

^b Catholic Cancer Center   (South Korea)

^c Samsung Medical Center   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CARCINOGENESIS; DNA INTEGRATION; EPISOME; FEMALE; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 0031127517     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4596     Document Type: Article

References (39)

1. 1. zur Hausen H: Papillomaviruses in anogenital cancer as a model to understanding the role of viruses in human cancers. Cancer Res 49:4677-4681, 1989
2. 2. Lorincz AT, Reid R, Jensen AB, Greenberg MD, Lancaster W, Kurman RJ: Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol 79:328-337, 1992
3. 3. Park JS, Chee YH, Namkoong SE, Han SK, Kim TE, Lee HY, Kim SJ: Human papillomavirus detection in cervical carcinoma tissues and paraaortic nodes by the polymerase chain reaction. Gynecol Oncol 53:344-351, 1994
4. 4. Woodworth CD, Doniger J, DiPaola JA: Immortalization of human keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol 63:159-164, 1989
5. 5. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79, 1990
6. 6. DiMaio D: Transforming activity of bovine and human papillomaviruses in cultured cells. Adv Cancer Res 56:133-159, 1991
7. 7. Shah KV, Howley PM: Papillomaviruses, in Fields BN, Knipe DM (eds): Virology. New York, Raven Press, 1990, pp 1651-1675
8. 8. Matsukura T, Koi S, Sugase M: Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 172:63-72, 1989
9. 9. Cullen AP, Reid R, Campion M, Lorincz AT: Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive neoplasm. J Virol 65:606-612, 1991
10. 10. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM: Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61:962-973, 1987
11. 11. Dyson M, Howley PM, Munger K, Harlow E: The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937, 1989
12. 12. Scheffner M, Werness BA, Huibretse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 63:1129-1136, 1990
13. 13. Park JS, Rhyu KS, Kim CJ, Kim HS, Han KT, Ahn HK, Kim SJ, Namkoong SE: Presence of oncogenic HPV DNAs in cervical carcinoma tissues and pelvic lymph nodes associating with proliferating cell nuclear antigen expression. Gynecol Oncol 60:418-423, 1996
14. 14. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503-517, 1975
15. 15. Saiki RK, Bugawa TL, Horn GT, Erlich HA: Analysis of enzymatically amplified beta-globin and HLA-DQ-alpha DNA with allele-specific oligonucleotide probes. Nature 324:163-166, 1986
16. 16. Snijders PJ, Meijer CLM, van den Brule AJC, Schrijnemakers HF, Snow GB, Walboomers JMM: Human papillomavirus type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. J Gen Virol 73:2059-2066, 1992
17. 17. Brinton LA: Epidemiology of Cervical Cancer - Overview, in Munoz N, Bosch FX, Shah KV (eds): The Epidemiology of Cervical Cancer and Human Papillomavirus. Oxford, Oxford Univ. Press, 1992, pp 3-23
18. 18. Wadanabe S, Kanda T, Yoshike K: Human papillomavirus type 16 transformation of human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol 63:965-969, 1989
19. 19. Riou G, Barrios M, Le MG, et al.: C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet 7:761-763, 1987
20. 20. Harper JW, Adami GR, Wei N, Keymarsi K, Elledge SJ: The p21 cdk-interacting protein cip 1 is a potent inhibitor of G1 cyclin dependent kinase. Cell 75:805-816, 1993
21. 21. El Awady MK, Kaplan JB, O'Brien SJ, et al.: Molecular analysis of integrated human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 159:389-398, 1987
22. 22. Lehn H, Villa LL, Marziona F, Hilgrath M, Hillemans HG, Sauer G: Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. J Gen Virol 69:187-196, 1988
23. 23. Romanczuk H, Thierry F, Howley PM: Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 p97 and type 18 p105 promoters. J Virol 64:2849-2859, 1990
24. 24. Thierry F, Howley PM: Functional analysis of E2-mediated repression of the HPV 18 p105 promoter. New Biol 3:90-100, 1991
25. 25. Chen SL, Han PH, Tsao YP, Lee JW, Yin CS: Identification and typing of human papillomavirus in cervical cancers in Taiwan. Cancer 72:1939-1945, 1993.
26. 26. Das BC, Sharma JK, Gopalakrishna V, Luthra UK: Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 73:2327-2336, 1992
27. 27. Schneider-Maunoury S, Croissant O, Orth G: Integration of human papillomavirus type 16 DNA sequences: Possible early event in the progression of genital tumors. J Virol 61:3295-3298, 1987
28. 28. Ham J, Dostatni N, Gautier JM, Yaniv M: The papillomavirus E2 protein: A factor with many talents. Trends Biochem Sci 16:440-444, 1991
29. 29. McBride AA, Romanczuk H, Howley PM: The papillomavirus E2 regulatory proteins. J Biol Chem 266:18411-18414, 1991
30. 30. Galehouse D, Jenison E, DeLucia A: Differences in the integration pattern and episomal forms of human papillomavirus type 16 DNA found within an invasive cervical neoplasm and its metastasis. Virology 186:339-341, 1992
31. 31. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jensen AB, Temple GF, Lorincz AT: Analysis of individual human papillomavirus types in cervical neoplasia: A possible role for type 18 in rapid progression. Am J Obstet Gynecol 159:293-296, 1988
32. 32. Walker J, Bloss JD, Liao SY, Berman M, Bergen M, Wilczynski SP: Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet Gynecol 74:781-783, 1989
33. 33. Barbosa MS, Edmonds C, Fisher C, Schiller JT, Lowy DR, Vousden KM: The region of the oncoprotein homologous to adenovirus E1A and SV 40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J 9:153-160, 1990
34. 34. Munger K, Yee CL, Phelps WC, Pietenpol JA, Moses HL, Howley PM: Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences. J Virol 65:3943-3948, 1991
35. 35. Stoler MH, Rhodes CR, Whitbeck A, Woilisky SM, Chow LT, Broker TR: Human papillomavirus type 16 and 18 gene expression in cervical neoplasia. Hum Pathol 23:117-128, 1992
36. 36. Vormwald-Dogan V, Fischer B, Bludau H, Freese UK, Gissmann L, Glitz D, Schwarz E, Durst M: Sense and antisense transcripts of human papillomavirus type 16 in cervical cancers. J Gen Virol 73:1833-1838, 1992
37. 37. Durst M, Bosch FX, Glitz D, Schneider A, zur Hausen H: Inverse relationship between human papillomavirus type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines. J Virol 65:796-804, 1991
38. 38. Jeon S, Lambert PF: Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of the E6 and E7 mRNAs: Implications for cervical carcinogenesis. Proc Natl Acad Sci USA 92:1654-1658, 1995
39. 39. May M, Dong XP, Beyer-Finkler E, Stubenrauch F, Pfister H: The E6/ E7 promoter of extrachromosomal HPV 16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J 13:1460-1466, 1994.